This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Magitha Maheshwar: Innovator in Tuberous Sclerosis Research
Introduction
Magitha Maheshwar is a notable inventor based in Mid Glamorgan, GB. He has made significant contributions to the field of genetics, particularly in relation to tuberous sclerosis. His work focuses on understanding the genetic underpinnings of this disorder and developing potential diagnostic and therapeutic approaches.
Latest Patents
Magitha Maheshwar holds a patent titled "Tuberous sclerosis 2 gene and uses thereof." This patent addresses tuberous sclerosis (TSC), an autosomal dominant disorder characterized by the widespread development of growths in various tissues and organs. The gene (TSC2) identified on chromosome 16 is mutated in TSC and may function as a tumor suppressor. Screening for normal or mutated TSC2 in actual or suspected TSC patients can be utilized for diagnostic purposes. Additionally, the TSC2 protein, known as tuberin, may be employed to treat or prevent unrestrained cell division and/or tumor development in patients with or without TSC. Magitha has 1 patent related to this important research.
Career Highlights
Throughout his career, Magitha Maheshwar has focused on advancing the understanding of genetic disorders. His research has implications for both diagnosis and treatment, making a significant impact in the medical field. His dedication to this area of study has positioned him as a key figure in genetic research.
Collaborations
Magitha has collaborated with esteemed colleagues, including Julian R Sampson and Mark David Nellist. These partnerships have enhanced the scope and depth of his research, contributing to advancements in the understanding of tuberous sclerosis.
Conclusion
Magitha Maheshwar's work in the field of genetics, particularly regarding tuberous sclerosis, showcases his innovative spirit and commitment to improving patient outcomes. His contributions through his patent and collaborations highlight the importance of research in understanding complex genetic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile